PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 5, 2025Nature Communications18 citationsOpen Access

Cryo-EM structures of CRAF/MEK1/14-3-3 complexes in autoinhibited and open-monomer states reveal features of RAF regulation

View Full Paper
DJDong Man JangKBKayla BoxerBHByung Hak Ha

Key Points

  • The study finds that phosphorylation alters the conformation of CRAF, activating its kinase activity and enhancing oncogenic signaling.
  • Cryo-EM structures show a fully autoinhibited CRAF conformation and two distinct open monomer states revealing regulatory interactions.
  • This research employs cryo-electron microscopy to visualize the complex interactions among CRAF, MEK1, and 14-3-3 under various conditions.
  • These insights may help develop selective inhibitors to target CRAF signaling in cancer therapies.

Abstract

Abstract CRAF (RAF1) is one of three RAF-family kinases that initiate MAP kinase signaling in response to activated RAS and is essential for oncogenic signaling from mutant KRAS. Like BRAF, CRAF is regulated by 14-3-3 engagement and by intramolecular autoinhibitory interactions of its N-terminal regulatory region. Unlike BRAF, it is thought to require tyrosine phosphorylation in its N-terminal acidic (NtA) motif for full catalytic activation. Here we describe cryo-EM reconstructions of full-length CRAF in complex with MEK1 and a 14-3-3 dimer. These structures reveal a fully autoinhibited conformation analogous to that observed for BRAF and two “open monomer” states in which the inhibitory interactions of the CRD and 14-3-3 dimer are released or rearranged, but the kinase domain remains inactive. Structure-function studies of the NtA motif indicate that phosphorylation or acidic mutations in this segment increase catalytic activity by destabilizing the inactive conformation of the kinase domain. Collectively, these studies provide a structural foundation for understanding the shared and unique regulatory features of CRAF and will inform efforts to selectively block CRAF signaling in cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jang et al. (2025) studied this question.

synapsesocial.com/papers/68bb4d2d6d6d5674bcd016eehttps://doi.org/10.1038/s41467-025-63227-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Accurate structure prediction of biomolecular interactions with AlphaFold 32024 · 15,609 citations
  2. 2Cryo-EM structure of a RAS/RAF recruitment complex2023 · 49 citations
  3. 3Oncogenic Signaling Pathways in The Cancer Genome Atlas2018 · 3,443 citations
  4. 4The role of CRAF in cancer progression: from molecular mechanisms to precision therapies2024 · 41 citations
  5. 5Regulation of RAF protein kinases in ERK signalling2015 · 715 citations